Immunoprecise Antibodies shares owned by Morgan Stanley
Quarter-by-quarter ownership of Immunoprecise Antibodies (IPA) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Immunoprecise Antibodies
Tip: Access up to 7 years of quarterly data
All positions including Immunoprecise Antibodies held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunoprecise Antibodies by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $11k | 11k | 1.01 |
| 2024-03-31 | $16k | 11k | 1.52 |
| 2023-12-31 | $18k | 11k | 1.71 |
| 2023-09-30 | $975 | 533 | 1.83 |
| 2023-06-30 | $1.6k | 533 | 2.96 |
| 2022-12-31 | $2.8k | 533 | 5.21 |
| 2022-06-30 | $6.0k | 1.6k | 3.67 |
| 2022-03-31 | $20k | 3.8k | 5.20 |
| 2021-06-30 | $63k | 11k | 5.98 |
| 2020-12-31 | $31k | 2.1k | 14.76 |